GO:0006622 protein targeting to lysosome: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006622 (protein targeting to lysosome) describes the directed transport of proteins to the lysosome using intrinsic sorting signals, a process essential for lysosomal function and cellular homeostasis [1,8].
• Lysosome-targeting chimeras (LYTACs) and genetically engineered lysosome-targeting exosomes exploit this pathway to degrade extracellular and membrane proteins, expanding the druggable proteome [1,2,5].
• Key molecular players include lysosomal membrane proteins such as LAMP1, LAMP2, and the mannose-6-phosphate receptor pathway, which are critical for delivering acid hydrolases.
• LRRK2 regulates lysosomal tubulation and vesicle sorting, linking protein targeting to lysosome to Parkinson's disease pathogenesis.
• The transcription factor TFEB coordinates lysosomal biogenesis and autophagy in response to lysosomal calcium signaling, indirectly influencing protein targeting capacity.
• Dysregulation of protein targeting to lysosome is implicated in neurodegeneration, cancer, and lysosomal storage disorders, making it a therapeutic target [3,4,7].
Description
Protein targeting to lysosome (GO:0006622) is the biological process that directs proteins towards the lysosome using signals contained within the protein itself. This sorting mechanism ensures that newly synthesized acid hydrolases and membrane proteins reach the lysosome, where they execute degradative and signaling functions. The pathway is fundamental for cellular clearance, nutrient sensing, and membrane remodeling, and its dysfunction underlies a range of human diseases [1,8]. Researchers study this process to understand lysosomal biology, to develop targeted protein degradation strategies, and to model diseases such as Parkinson's and lysosomal storage disorders [1,4,5]. The emergence of lysosome-targeting chimeras (LYTACs) and genetically engineered exosomes has highlighted the therapeutic potential of hijacking endogenous lysosomal targeting machinery [1,2,5]. Thus, GO:0006622 represents a convergence point for basic cell biology and next-generation therapeutics.
protein targeting to lysosome At A Glance
| GO ID | GO:0006622 |
|---|---|
| GO term | protein targeting to lysosome |
| Ontology | biological_process |
| Synonym | protein-lysosome targeting |
| Definition | The process of directing proteins towards the lysosome using signals contained within the protein. |
| Major function | Sorting and delivery of proteins to the lysosome for degradation, signaling, and homeostasis. |
| Related pathways | Lysosomal biogenesis, autophagy, endosomal sorting, LYTAC-mediated degradation. |
| Key molecules | LAMP1, LAMP2, M6PR, LRRK2, TFEB, and lysosomal hydrolases. |
| Disease relevance | Neurodegeneration, cancer, lysosomal storage disorders. |
What Is GO:0006622?
According to the Gene Ontology, protein targeting to lysosome (GO:0006622) is the process of directing proteins towards the lysosome using signals contained within the protein. This includes the recognition of sorting motifs, vesicular transport, and delivery to the lysosomal compartment, ensuring proper localization of both soluble and membrane proteins.
Why Is protein targeting to lysosome Important in Cell Biology?
Protein targeting to lysosome is essential for maintaining cellular proteostasis and energy balance. Defects in this pathway lead to accumulation of undegraded substrates, impaired autophagy, and cellular toxicity, which are hallmarks of lysosomal storage disorders and neurodegenerative diseases [4,7]. Moreover, the pathway is now exploited for therapeutic protein degradation, as seen with LYTACs and HerTACs, offering new avenues to target previously undruggable proteins [1,5]. Understanding the molecular signals and machinery involved is therefore critical for both basic research and drug development.
• Maintains lysosomal function by delivering acid hydrolases and membrane proteins.
• Regulates autophagy and cellular clearance through TFEB-mediated lysosomal biogenesis.
• Implicated in Parkinson's disease via LRRK2-mediated lysosomal tubulation.
• Enables targeted protein degradation of extracellular and membrane proteins using LYTACs.
• Provides a mechanism for tumor-selective degradation via HER2 trafficking (HerTACs).
• Dysfunction leads to lysosomal membrane permeabilization and cell death.
• Sulforaphane activates a lysosome-dependent transcriptional program to mitigate oxidative stress.
• Engineered exosomes can deliver degraders to lysosomes for targeted protein knockdown.
• Serves as a model for studying vesicle trafficking and organelle biogenesis.
• Offers therapeutic opportunities for cancer, neurodegeneration, and rare genetic diseases [1,4,5].
What Happens During protein targeting to lysosome?
Signal Recognition and Cargo Selection
In simple terms: Proteins destined for the lysosome carry a molecular 'zip code' that is recognized by sorting machinery.
The process begins with the recognition of sorting signals within the protein sequence or attached glycans, such as mannose-6-phosphate (M6P) tags on acid hydrolases. These signals are recognized by receptors like the cation-dependent and cation-independent M6P receptors, which capture the cargo and direct it to the endosomal system. In neurons, spatiotemporal proteomics has revealed a complex interactome of biosynthetic lysosomal membrane proteins, highlighting the diversity of cargo and sorting factors.
Vesicular Transport and Endosomal Sorting
In simple terms: Cargo-loaded vesicles bud off and travel to the endosome, where sorting decisions are made.
Following recognition, cargo-receptor complexes are packaged into clathrin-coated vesicles that fuse with early endosomes. The endosomal sorting complexes required for transport (ESCRT) machinery and Rab GTPases facilitate the segregation of lysosomal cargo from recycling receptors. LRRK2 has been shown to mediate tubulation and vesicle sorting from lysosomes, influencing the dynamics of this pathway. This step ensures that proteins are correctly routed to the lysosome while receptors are recycled.
Lysosomal Delivery and Membrane Fusion
In simple terms: The cargo vesicle fuses with the lysosome, releasing its contents into the acidic lumen.
Late endosomes/multivesicular bodies fuse with lysosomes, delivering their cargo. This fusion is mediated by SNARE proteins and regulated by lysosomal calcium signaling, which activates calcineurin and TFEB, promoting lysosomal biogenesis and function. The lysosomal membrane proteins LAMP1 and LAMP2 are critical for maintaining membrane integrity and facilitating fusion events. Defects in this step can lead to lysosomal membrane permeabilization, detectable by galectin puncta assays.
Receptor Recycling and Lysosomal Homeostasis
In simple terms: After delivery, receptors are sent back to the Golgi for another round, keeping the system efficient.
Following cargo release, M6P receptors are recycled from the endosome to the trans-Golgi network, a process dependent on retromer and Rab9. This recycling is essential for sustained lysosomal targeting. TFEB further coordinates lysosomal homeostasis by upregulating genes involved in lysosomal biogenesis and autophagy in response to stress. Sulforaphane has been shown to activate a lysosome-dependent transcriptional program that mitigates oxidative stress, underscoring the adaptive nature of this pathway.
Key Genes Involved in GO:0006622 protein targeting to lysosome
The following genes and proteins are central to protein targeting to lysosome, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LAMP1 | Lysosomal membrane protein, marker of lysosomes | Used as a lysosomal marker; involved in membrane fusion and integrity |
| LAMP2 | Lysosomal membrane protein, protects membrane | Mutations cause Danon disease; key for lysosomal targeting |
| M6PR (IGF2R) | Mannose-6-phosphate receptor, binds acid hydrolases | Essential for sorting of hydrolases to lysosome |
| LRRK2 | Regulates lysosomal tubulation and vesicle sorting | Implicated in Parkinson's disease; modulates lysosomal dynamics |
| TFEB | Transcription factor, master regulator of lysosomal biogenesis | Coordinates lysosomal and autophagic gene expression |
| CALCINEURIN | Calcium-dependent phosphatase, activates TFEB | Links lysosomal calcium signaling to autophagy |
| GALECTIN-3 | Binds exposed glycans on damaged lysosomes | Marker of lysosomal membrane permeabilization |
| HER2 (ERBB2) | Receptor tyrosine kinase, target of HerTACs | Enables tumor-selective lysosomal degradation |
| CTSD | Lysosomal aspartyl protease | Acid hydrolase delivered via M6P pathway |
| CTSB | Lysosomal cysteine protease | Involved in protein turnover and antigen presentation |
| GBA | Glucocerebrosidase | Mutations cause Gaucher disease; linked to Parkinson's |
| SNARE proteins | Mediate vesicle fusion | Essential for lysosomal delivery |
| Rab7 | Late endosome/lysosome GTPase | Regulates endosomal sorting and fusion |
| Rab9 | Recycles M6P receptors | Required for retrograde transport |
| ESCRT components | Sort cargo into multivesicular bodies | Facilitate lysosomal targeting of membrane proteins |
| mTORC1 | Kinase complex, inhibits TFEB | Regulates lysosomal biogenesis in response to nutrients |
| SLC38A9 | Lysosomal arginine sensor | Activates mTORC1, linking lysosomal amino acids to growth |
How Is protein targeting to lysosome Regulated?
Protein targeting to lysosome is regulated at multiple levels. The transcription factor TFEB is a master regulator that translocates to the nucleus upon lysosomal calcium signaling and calcineurin activation, driving expression of lysosomal and autophagic genes. mTORC1, a nutrient sensor, phosphorylates TFEB and retains it in the cytoplasm under nutrient-rich conditions, thereby inhibiting lysosomal biogenesis. LRRK2 modulates lysosomal tubulation and vesicle sorting, and its kinase activity is linked to Parkinson's disease. Additionally, sulforaphane activates a lysosome-dependent transcriptional program that mitigates oxidative stress, indicating that environmental stressors can modulate this pathway.
protein targeting to lysosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRRK2 | Parkinson's disease | Knock-in of G2019S mutation in iPSC-derived neurons |
| GBA | Gaucher disease, Parkinson's risk | Knockout or point mutation in SH-SY5Y cells |
| LAMP2 | Danon disease | Knockout in cardiomyocytes |
| HER2 (ERBB2) | Breast cancer, HerTAC target | Overexpression in SK-BR-3 cells |
| M6PR (IGF2R) | Lysosomal storage disorders | Knockout in HeLa cells |
Neurodegeneration and Parkinson's Disease
Dysregulation of protein targeting to lysosome contributes to neurodegeneration. LRRK2 mutations, common in Parkinson's disease, impair lysosomal tubulation and vesicle sorting, leading to accumulation of alpha-synuclein and neuronal toxicity. GBA mutations, which cause Gaucher disease, also increase Parkinson's risk by disrupting lysosomal hydrolase delivery. Lysosomal membrane permeabilization, detected by galectin puncta, is a marker of neuronal cell death in these conditions.
Cancer and Targeted Protein Degradation
Cancer cells often upregulate lysosomal function to support growth and survival. HerTACs exploit HER2 trafficking to deliver membrane and extracellular proteins to lysosomes for degradation, offering tumor-selective therapy. LYTACs similarly hijack lysosomal targeting to degrade extracellular proteins, expanding the scope of targeted protein degradation. Engineered lysosome-targeting exosomes provide another platform for delivering degraders.
Lysosomal Storage Disorders
Mutations in genes encoding lysosomal hydrolases or sorting receptors cause lysosomal storage disorders. Defective mannose-6-phosphate tagging leads to missorting of hydrolases, resulting in substrate accumulation. Understanding protein targeting to lysosome is essential for developing therapies such as enzyme replacement or chaperone therapy.
From protein targeting to lysosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LRRK2 affect lysosomal tubulation? | LRRK2 knockout in iPSC-derived neurons |
| How does GBA mutation impact lysosomal targeting? | GBA point mutation (N370S) knock-in in SH-SY5Y |
| Can LAMP2 be tagged to track lysosomal delivery? | LAMP2 knock-in with GFP tag in HeLa |
| Does HER2 overexpression enhance HerTAC efficacy? | HER2 overexpression in MDA-MB-231 |
| What is the role of TFEB in lysosomal biogenesis? | TFEB knockout in HeLa, treated with Torin1 |
| Does M6PR recycling require Rab9? | Rab9 knockout in HeLa, pulse-chase |
How to Study the protein targeting to lysosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spatiotemporal proteomics | Protein interactions and dynamics | Mapping lysosomal membrane interactome |
| Galectin puncta assay | Lysosomal membrane permeabilization | Detecting lysosomal damage |
| Live-cell imaging | Vesicle trafficking and tubulation | Visualizing LRRK2-mediated sorting |
| RNA-seq | Transcriptional changes | Sulforaphane-induced lysosomal program |
| Western blot | Protein degradation | LYTAC/HerTAC efficacy [1,5] |
| CRISPR knockout screen | Gene essentiality for targeting | Identifying novel sorting factors |
| Proximity labeling | Interactome mapping | Discovering cargo-receptor interactions |
| Flow cytometry | Surface protein levels | HerTAC-mediated degradation |
Proteomics and Interactome Analysis
Spatiotemporal proteomics can reveal the biosynthetic lysosomal membrane protein interactome in neurons, identifying novel sorting factors and cargo. Proximity labeling and immunoprecipitation coupled to mass spectrometry are powerful for mapping dynamic interactions during targeting.
Imaging and Vesicle Tracking
Fluorescence microscopy with tagged lysosomal markers (e.g., LAMP1-GFP) allows real-time visualization of vesicle trafficking. Galectin puncta assays detect lysosomal membrane permeabilization, a readout of targeting defects. Live-cell imaging of LRRK2-mediated tubulation provides insights into sorting dynamics.
Transcriptional and Functional Assays
TFEB nuclear translocation can be monitored by immunofluorescence or luciferase reporters. Sulforaphane-induced lysosomal transcriptional programs can be assessed by RNA-seq. LYTAC and HerTAC degradation efficacy is measured by western blot or flow cytometry [1,5].
Genetic Screens and CRISPR Libraries
Genome-wide CRISPR knockout screens can identify genes required for lysosomal targeting. Focused libraries targeting vesicle trafficking genes enable high-throughput discovery of sorting regulators. Bioinformatics analysis of screen hits reveals enriched pathways and networks.
How CRISPR Can Be Used to Study GO:0006622 protein targeting to lysosome
Knockout
CRISPR knockout of genes such as LRRK2, GBA, or M6PR can reveal their requirement for protein targeting to lysosome. For example, LRRK2 knockout in neurons impairs lysosomal tubulation, providing causal evidence for its role. Knockout of LAMP2 destabilizes lysosomal membranes and affects targeting.
Point Mutation
Introducing disease-associated point mutations, such as LRRK2 G2019S or GBA N370S, allows study of how specific alleles affect lysosomal targeting. These models mimic human disease and can be used to test targeted therapies.
Knock-in
Knock-in of tagged versions of lysosomal proteins (e.g., LAMP1-GFP) enables real-time tracking of targeting in live cells. This approach is valuable for studying vesicle dynamics and sorting signals.
Overexpression
Overexpression of HER2 or other cargo proteins can enhance lysosomal degradation via HerTACs or LYTACs, providing a platform to test degradation efficiency [1,5]. Overexpression of TFEB promotes lysosomal biogenesis and can rescue targeting defects.
How EDITGENE Supports protein targeting to lysosome Research
Researchers studying protein targeting to lysosome-related genes often need to determine whether a candidate gene is causally involved in sorting, delivery, or lysosomal function. CRISPR-based models provide precise tools to dissect these mechanisms and validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for protein targeting to lysosome research.
Frequently Asked Questions About protein targeting to lysosome
What is protein targeting to lysosome (GO:0006622)?
It is the biological process of directing proteins to the lysosome using intrinsic sorting signals, ensuring proper delivery of hydrolases and membrane proteins.
What genes are involved in protein targeting to lysosome?
Key genes include LAMP1, LAMP2, M6PR, LRRK2, TFEB, GBA, and Rab GTPases, among others [4,6,8].
How is protein targeting to lysosome regulated?
It is regulated by TFEB, mTORC1, lysosomal calcium signaling, and LRRK2-mediated tubulation [4,6].
What diseases are linked to defects in protein targeting to lysosome?
Neurodegeneration (Parkinson's disease), lysosomal storage disorders, and cancer [4,5,8].
What are LYTACs and how do they relate to lysosomal targeting?
LYTACs are chimeric molecules that hijack lysosomal targeting to degrade extracellular proteins.
Can CRISPR be used to study protein targeting to lysosome?
Yes, CRISPR knockout, knock-in, and point mutation models enable precise dissection of sorting mechanisms [4,8].
What methods are used to study lysosomal targeting?
Proteomics, live-cell imaging, galectin puncta assays, RNA-seq, and CRISPR screens [3,7,8].
What is the role of LRRK2 in lysosomal targeting?
LRRK2 mediates tubulation and vesicle sorting from lysosomes, and mutations are linked to Parkinson's disease.
How does TFEB control lysosomal targeting?
TFEB is a transcription factor that upregulates lysosomal and autophagic genes in response to calcium signaling.
What cell models are available for studying lysosomal targeting?
Knockout, point mutation, knock-in, and overexpression models in cell lines such as HeLa, SH-SY5Y, and iPSC-derived neurons [4,5,8].
Conclusion
Protein targeting to lysosome (GO:0006622) is a fundamental cellular process that ensures proper delivery of proteins to the lysosome, with far-reaching implications for health and disease. From neurodegeneration to cancer, understanding the molecular signals and machinery involved opens new therapeutic avenues, including targeted protein degradation. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate this pathway and its potential for clinical translation.
References
- 1. Banik SM et al.. 2020. Lysosome-targeting chimaeras for degradation of extracellular proteins.. Nature 584(7820):291-297 PMID: 32728216
- 2. Wang T et al.. 2023. Targeted Protein Degradation Mediated by Genetically Engineered Lysosome-Targeting Exosomes.. Nano Lett 23(20):9571-9578 PMID: 37823825
- 3. Li D et al.. 2021. Sulforaphane Activates a lysosome-dependent transcriptional program to mitigate oxidative stress.. Autophagy 17(4):872-887 PMID: 32138578
- 4. Bonet-Ponce L et al.. 2020. LRRK2 mediates tubulation and vesicle sorting from lysosomes.. Sci Adv 6(46) PMID: 33177079
- 5. He S et al.. 2025. HerTACs Enable Tumor-Selective Lysosomal Degradation of Membrane and Extracellular Proteins via HER2 Trafficking.. Angew Chem Int Ed Engl 64(41):e202511467 PMID: 40838532
- 6. Medina DL et al.. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB.. Nat Cell Biol 17(3):288-99 PMID: 25720963
- 7. Aits S et al.. 2015. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay.. Autophagy 11(8):1408-24 PMID: 26114578
- 8. Li CH et al.. 2024. Spatiotemporal proteomics reveals the biosynthetic lysosomal membrane protein interactome in neurons.. Nat Commun 15(1):10829 PMID: 40016183
